Atopic Dermatitis

Adbry 300 mg/2 mL single-dose autoinjector is now available for the treatment of adults with moderate to severe atopic dermatitis in the U.S., LEO Pharma announced in a press release.

Eli Lilly and Company announced it received FDA approval for Ebglyss for the treatment of moderate-to-severe atopic dermatitis that is not well controlled with topical prescription therapies, according to a company press release.

Researchers confirmed that the interleukin-1 receptor-associated kinase 4 protein plays a role in the pathogenesis of hidradenitis suppurativa and that a degrader treatment may impact the disease, according to a study.

Fish oil supplementation during pregnancy was associated with children having a lower or higher risk for developing atopic dermatitis depending on the mother’s genotype, according to a study.

Children with diverse skin types with atopic dermatitis-prone skin did not experience any adverse events when using a sunscreen formulated with antioxidants, according to a study.

Gaining weight can raise the risk for atopic dermatitis and possibly other immune-mediated skin diseases in children, whereas losing weight can reduce this risk, according to a study.

To overcome barriers to biologic care for patients with asthma, personalized treatment is key, according to a speaker at the 16th Annual Allergy, Asthma & Immunology CME Conference.

The National Psoriasis Foundation dedicated August to psoriasis education, awareness and education, designating it Psoriasis Action Month.

SAN ANTONIO — How good are home allergy tests? Should patients pause biologic treatment before oral food challenges? Is it possible to stop pediatricians from ordering so many food panels? Is skin prick testing needed before OFCs?

Peanut and egg were found to be new triggers for food protein-induced enterocolitis syndrome, and milk and oat surpassed rice as the most common triggers, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.